臨床婦人科産科71巻1号

2017年01月発行

合併増大号　今月の臨床 性ステロイドホルモン研究の最前線と臨床応用 選択的性ステロイドホルモン受容体修飾薬

tissue selective estrogen complex（TSEC）

著者： 大石元¹ 矢野哲¹

所属機関： ¹国立国際医療研究センター病院産婦人科

ページ範囲：P.133 - P.138

●HRTの合併症は，子宮内膜保護を目的に併用するプロゲスチンに起因するところが大きい．

●組織特異的なエストロゲン作用をもつSERMをエストロゲンと併用するTSECが開発され，臨床応用されている．

●今後TSECがHRTに代わりうる更年期症状の治療手段として期待される．

参考文献

1）Chlebowski RT, et al : Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women : the Women's Health Initiative Randomized Trial. JAMA 289 : 3243─3253, 2003

2）Anderson GL, et al : Effects of conjugated equine estrogen in postmenopausalwomenwith hysterectomy. TheWomen's Health Initiative randomized controlled trial. JAMA 291 : 1701─1712, 2004

3）Palacios S, et al : Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause : A practical guide. Maturitas 80 : 435─440, 2015

4）Santen RJ, et al : Current and Evolving Approaches to Individualizing Estrogen Receptor-Based Therapy for Menopausal Women. J Clin Endocrinol Metab 99 : 733─747, 2014

5）Mirkin S, et al : Tissue-selective estrogen complexes for postmenopausal women. Maturitas 76 : 213─220, 2013

6）Pazhekattu R, et al : The Tissue-Selective Estrogen Complex : A Review of Current Evidence. Rheumatol Ther 2 : 47─58, 2015

7）Lindsay R, et al : Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens forosteoporosis prevention in at-risk postmenopausal women. Fertil Steril 92 : 1045─1052, 2009

8）Pinkerton JV, et al : Effects of bazedoxifene/conjugated estrogens on the endometrium and bone : a randomized trial. J Clin Endocrinol Metab 99 : 189─198, 2014

9）Lobo R, et al : Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile. Fertil Steril 92 : 1025─1038, 2009

10）Kagan R, et al : A randomized, placebo-and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women. Menopause 17 : 281─289, 2010

11）de Villiers TJ, et al : Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis : results of a 5-year, randomized, placebo-controlled phase 3 trial. Osteoporos Int 22 : 567─576, 2011